-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Na+jUf1AAWV/7qUU+PDjT+tbUsSTjz+79ky3Le+Q2EAbJFMKEpg0szeHYcEHh+GH +d6XLJScWWJ4QGiET4D3rg== /in/edgar/work/0001095811-00-004102/0001095811-00-004102.txt : 20001027 0001095811-00-004102.hdr.sgml : 20001027 ACCESSION NUMBER: 0001095811-00-004102 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20001026 FILER: COMPANY DATA: COMPANY CONFORMED NAME: KINESYS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001096328 STANDARD INDUSTRIAL CLASSIFICATION: [2834 ] STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 15-12G SEC ACT: SEC FILE NUMBER: 000-27571 FILM NUMBER: 746614 BUSINESS ADDRESS: STREET 1: 3771 JACOMBS ROAD STREET 2: UNIT 415 CITY: RICHMOND BC CANADA BUSINESS PHONE: 6042790363 MAIL ADDRESS: STREET 1: 3771 JACOMBS ROAD UNIT 415 CITY: RICHMOND BC CANADA STATE: A1 15-12G 1 a66557e15-12g.txt FORM 15-12G 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 000-27571 KINESYS PHARMACEUTICALS, INC. - -------------------------------------------------------------------------------- (Exact name of registrant as specified in its charter) 3771 Jacombs Road, Unit 415, Richmond, BC, Canada V6V2L9 - -------------------------------------------------------------------------------- (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) Common Stock - -------------------------------------------------------------------------------- (Title of each class of securities covered by this Form) None - -------------------------------------------------------------------------------- (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains) Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports: Rule 12g-4(a)(1)(i) [x] Rule 12h-3(b)(1)(i) [x] Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(1)(ii) [ ] Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(i) [ ] Rule 12g-4(a)(2)(ii) [ ] Rule 12h-3(b)(2)(ii) [ ] Rule 15d-6 [ ] Approximate number of holders of record as of the certification or notice date: 125 Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person. Date: October 20, 2000 By: /s/ JEFF KLETTER, PRESIDENT ------------------ -------------------------------- JEFF KLETTER, PRESIDENT Instruction: This form is required by Rules 12g-4, 12h-3 and 15h-3 and 15d-6 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature. -----END PRIVACY-ENHANCED MESSAGE-----